Summit Partners

Summit Partners, founded in 1984, is a global alternative investment firm managing more than $9.5 billion across growth equity, fixed income, and public equity opportunities. The firm has invested in over 460 companies primarily in technology, healthcare, and life sciences, facilitating more than 140 public offerings and 180 strategic mergers and sales. Summit Partners focuses on rapidly growing companies with established business models and strong revenue and earnings growth. Its investment range typically spans from $10 million to over $500 million, allowing for substantial capital deployment in individual companies. The firm enhances the value of its portfolio through infrastructure development, executive recruitment, and strategic advisory services. With offices in Boston, Menlo Park, and London, Summit employs over 90 investment professionals dedicated to various sectors, including business services, consumer products, and media.

Jeffrey Allen

Associate

Donald Allen

Director of Portfolio Technology

Dessi K. Andreeva

Manager of General Partner Financial Reporting

Aleksandra Antolak

Associate

David Averett

Managing Director

Gregory M. Avis

Cofounder and Senior Advisor

Susan Barr

Vice President of Marketing

Chris Bon

vice_president

Adam Britt

Managing Director

Blake Brown

Associate

Gabriel Carreiro

Vice President

Hanyin Cheng

vice_president

Eunji Chung

Vice President

Antony Clavel

Managing Director

Andrew Collins

Managing Director

Andrea Costantino

Vice President

Kevin R. Curtin

Associate

Luna Dai

Vice President

Robin Winters Devereux

Managing Director and Chief Financial Officer

Margaret Riley Devine

Chief Marketing Officer

Ali Dowd

VP

Shaun Dunlop

Associate

Kelly A. Echavarria

Associate

Harry Fackelmayer

Associate

Robert Fee

vice_president

Scott Ferguson

Principal

Leonard Ferrington

Managing Director

Charles J. Fitzgerald

MD

Peter A. Francis

Managing Director

Paul Furer

Principal

Philip Charles Furse

Portfolio Manager and CIO of Public Equity

Jonathan H. Gilman

Associate

Greg S. Goldfarb

Managing Director

John Gonneville

Associate

Johannes N. Grefe

Managing Director

Thomas W. Guilfoile

Associate

Angela J. Ha

Associate

William W. Harrison

Associate

Robert Hassell

Managing Director

Mats Heimes

VP

Adam Hennessey

Managing Director and CFO

Andrew Hilboldt

Associate

Madeline K. Hwang

Associate

Kevin B. Jacobson

Associate

Adesh S. Jain

Vice President

Thomas H. Jennings

Managing Director

Chelsea L. Jurman

Vice President on the Growth Products & Services

Brandon Kearse

Associate

Dennis Kim

Senior Associate

John T. Koo

Associate

Walter Kortschak

Managing Partner

Jesse E. Lane

Principal

Andrew S. Lee

Vice President

Olivia G. Ley

Associate

Michael A. Lukasek

VP of Finance

Martin Mannion

Investor

Samuele Mazzoli

Associate

Greg McDouglas

Associate

Michael A. Medici

Managing Director

Edward Patrick Meissner

VP and Corporate Controller

Colin Mistele

Managing Director

Robert Mlnarik

Senior Associate

Sergio Mur

Principal

Matthew R. Nash

Associate

Peter Nielsen

Associate

Leslie A. Noonan

Vice President of Taxation

Mark T. Nordstrom

Principal, Capital Markets

Luke Nowicki

Associate

Nik Ohri

Associate

Jono Pagden

vice_president

Nancy Parrish

Investor Relations Officer

Luke Parsons

Vice President

John Partridge

Partner

Jay D. Pauley

Managing Director

Steffan K. Peyer

Managing Director

Alex Phelan

Associate

Sophia Popova

Principal

Niclas Priess

Associate

Catherine F. Rohr

Associate

Neil Roseman

Investor

Ian Rothkopf

VP

Paul De Sadeleer

Associate

David Schiller

Chief Investor Relations Officer

Dean J. Serure

Associate

Jessie T. Sheff

Associate

William Sheldon

Senior Associate

Han Sikkens

Managing Director and Head of Europe

Nicolas Slim

VP

Jeffrey J. Stapleton

Associate

Ross Stern

Managing Director

Christian Strain

Managing Director

Thomas Tarnowski

Managing Director

Patrick M. Twomey

Associate

Steven Twomey

Principal

Thomas Usher

Senior Associate

Erin M. Valenti

Senior Associate

Caitlin M. Vorlicek

Associate

Melanie Whelan

Managing Director

Alexander D. Whittemore

MD, Capital Markets

Mark A. deLaar

Managing Director

C. J. Fitzgerald

Investor

Past deals in South Carolina

Ob Hospitalist Group

Private Equity Round in 2010
Ob Hospitalist Group provides on-site, board-certified obstetrics and gynecology physician services to hospitals across the United States. Founded in 2006 and based in Mauldin, South Carolina, with additional locations in Greenville and Houston, the company focuses on developing and managing hospitalist programs that ensure expectant mothers receive reliable medical care. Its dedicated team of skilled physicians is available 24/7, providing both emergent and routine care in the absence of a private physician. By collaborating with hospitals and medical staff, Ob Hospitalist Group aims to enhance patient outcomes, support healthcare providers, and promote clinical excellence in women's health. The organization is committed to improving the overall standard of care for women and newborns through innovative and financially sustainable healthcare solutions.

Aurora Diagnostics

Private Equity Round in 2006
Aurora Diagnostics, LLC, a specialized laboratory company, provides unsurpassed diagnostic, prognostic, and therapeutic information and services to physicians, hospital systems, and researchers in the United States. It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women’s health care providerpathology. The company also provides molecular diagnostic services that focus on pharmacogenomics, oncology, women’s health, and infectious diseases; and hospital-based clinical and management solutions, such as anatomic and clinical, professional component, and technical component pathology services, as well as laboratory management services. It also serves dermatologists, OB/gynecological professionals, family practitioners, gastroenterologists, urologists, general surgeons, oncologists, and community-based hospitals. The company was founded in 2006 and is headquartered in Palm Beach Gardens, Florida. It has laboratory locations in Birmingham, Alabama; Jacksonville, Palm Beach Gardens, Tampa, Miami Lakes, and Coral Gables, Florida; Atlanta, Georgia; Boston, Massachusetts; Grand Rapids and Monroe, Michigan; Plymouth, Minnesota; Las Vegas and Reno, Nevada; Exeter, New Hampshire; Eatontown, New Jersey; Woodbury, New York; Greensboro, North Carolina; Ridgeland, South Carolina; and San Antonio, Texas. Aurora Diagnostics, LLC operates as a subsidiary of Aurora Diagnostics Holdings, LLC. As of January 30, 2019, Aurora Diagnostics, LLC operates as a subsidiary of Sonic Healthcare Limited.